位置:成果数据库 > 期刊 > 期刊详情页
罗哌卡因复合舒芬太尼腰麻在老年患者的应用
  • ISSN号:0253-3685
  • 期刊名称:《江苏医药》
  • 时间:0
  • 分类:R614[医药卫生—麻醉学;医药卫生—临床医学;医药卫生—外科学]
  • 作者机构:[1]右江民族医学院附属医院麻醉科,广西壮族自治区533000
  • 相关基金:基金项目:广西壮族自治区卫生厅自筹经费科研课题(7-2010089)作者单位:533000广西壮族自治区,右江民族医学院附属医院麻醉科
中文摘要:

目的:观察罗哌卡因复合舒芬太尼腰麻用于老年患者的麻醉效果。方法腰麻下行下肢手术老年(65—81岁)患者75例随机均分为三组。腰麻药物:A组,罗哌卡因15mg;B组,罗哌卡因10mg;C组,罗哌卡因10nag+舒芬太尼5bμg。记录注药前后MAP和HR变化、神经阻滞效果、术后镇痛维持时间和不良反应。结果腰麻给药后,A组MAP明显低于麻醉前和B、C组(P〈0.05);C组MAP下降比A组轻(P〈0.05)。C组术后镇痛维持时间与A组相仿,明显长于B组(P〈0.05)。与B、C组比较,A组感觉阻滞最高平面高,Bromage肌力评级高,运动神经阻滞持续时间长,术后尿潴留病例多(P〈0.05)。结论罗哌卡因10mg复合舒芬太尼5μg腰麻,效果确切,血流动力学稳定,不良反应少,是老年患者腰麻的良好选择。

英文摘要:

Objective To observe the outcomes of spinal anesthesia with ropivacaine combined with sufentanil in the elderly. Methods Spinal anesthesia was performed in 75 patients, aged 65-81 years old and undergoing selective lower limb surgery, who were equally randomized into three groups. The anasthetic drugs for spinal anesthesia were ropivacaine 15 mg in group A, ropivacaine 10 mg in group B and ropivacaine 10 mg plus sufentanil 5 μg in group C. The changes of MAP and HR were monitored before and in 20 rain after subarachnoid administration. The outcomes of nerve blockade, postoperative analgesia time and complications were recorded. Results After subarachnoid administration, MAP in group A was significantly lower than that before and that in groups of B and C (P〈0. 05),which in group C was not decreased significantly. The postoperative analgesia time in group C was similar to that in group A, but longer than that in group B(P〈0. 05). Compared to groups of B and C, the highest block plane was higher, Bromage grade was higher with longer motor blockade, and the cases with postoperative urinary retention were more in group A (P〈0. 05). Conclusion Spinal anesthesia with ropivacaine 10 mg combined with sufentanil 5μg can provide a sufficient nerve blockade with stable circulation and Jess postoperative adverse responses, which is a good choice for the elderly undergoing lower extremity surgery.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《江苏医药》
  • 北大核心期刊(2011版)
  • 主管单位:江苏省卫生厅
  • 主办单位:江苏省人民医院
  • 主编:
  • 地址:南京市广州路300号
  • 邮编:210029
  • 邮箱:yiya@chinajournal.net.cn
  • 电话:025-57711507 83216587
  • 国际标准刊号:ISSN:0253-3685
  • 国内统一刊号:ISSN:32-1221/R
  • 邮发代号:28-4
  • 获奖情况:
  • 中国科技论文统计源期刊,全国临床医学核心期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2000版)
  • 被引量:32760